Cargando…
BAD-mediated apoptotic pathway is associated with human cancer development
The malignant transformation of normal cells is caused in part by aberrant gene expression disrupting the regulation of cell proliferation, apoptosis, senescence and DNA repair. Evidence suggests that the Bcl-2 antagonist of cell death (BAD)-mediated apoptotic pathway influences cancer chemoresistan...
Autores principales: | STICKLES, XIAOMANG B, MARCHION, DOUGLAS C, BICAKU, ELONA, SAWAH, ENTIDHAR AL, ABBASI, FOROUGH, XIONG, YIN, ZGHEIB, NADIM BOU, BOAC, BERNADETTE M, ORR, BRIAN C, JUDSON, PATRICIA L, BERRY, AMY, HAKAM, ARDESHIR, WENHAM, ROBERT M, APTE, SACHIN M, BERGLUND, ANDERS E, LANCASTER, JOHNATHAN M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356438/ https://www.ncbi.nlm.nih.gov/pubmed/25653146 http://dx.doi.org/10.3892/ijmm.2015.2091 |
Ejemplares similares
-
A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth
por: MARCHION, DOUGLAS C., et al.
Publicado: (2013) -
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
por: Bansal, Nisha, et al.
Publicado: (2012) -
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival
por: Bicaku, E, et al.
Publicado: (2012) -
Expression of the BAD pathway is a marker of triple-negative status and poor outcome
por: Boac, Bernadette M., et al.
Publicado: (2019) -
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
por: CHEN, NING, et al.
Publicado: (2014)